0001372299-12-000003.txt : 20121126
0001372299-12-000003.hdr.sgml : 20121126
20121126133508
ACCESSION NUMBER: 0001372299-12-000003
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20121126
DATE AS OF CHANGE: 20121126
EFFECTIVENESS DATE: 20121126
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: HISTOGENICS CORP
CENTRAL INDEX KEY: 0001372299
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-181896
FILM NUMBER: 121223953
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-457-7900
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
D/A
1
primary_doc.xml
X0706
D/A
LIVE
0001372299
HISTOGENICS CORP
830 WINTER STREET
WALTHAM
MA
MASSACHUSETTS
02451
781-457-7900
DELAWARE
None
None
Corporation
true
Patrick
O'Donnell
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Director
Garheng
Kong
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Director
Joshua
Baltzell
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Director
Michael
Lewis
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Director
Kevin
McArdle
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Kevin
Rakin
c/o Histogenics Corporation
830 Winter Street, #3
Waltham
MA
MASSACHUSETTS
02451
Director
Biotechnology
Decline to Disclose
- 06
true
0001372299-12-000002
2012-07-20
true
true
true
true
true
In connection with the offering, the Company merged with Histogenics Finance Corporation, a Delaware corporation, with the Company continuing as the surviving entity. Such merger was effected solely for the purpose of reorganizing the Company's capital.
0
58286647
37638679
20647968
13 (a) and (b) include $6,250,000 attributed to the conversion of debt into shares of common stock and $2,786,647 attributed to the estimated value of the warrants.
false
13
0
0
0
false
HISTOGENICS CORP
/s/ Kevin McArdle
Kevin McArdle
CFO and Treasurer
2012-11-21